Stock Outstanding Shares
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
ShortableYes
OptionableYes
Short Percent Of Outstanding Shares1.59
Short Percent Of Float1.75
Shares Outstanding40.85M
Shares Float32.47M
Shares Short650.80K
Short Ratio5.46
1.75%
Short % of Float1.59%
Short % of Shares OutstandingMarket Insider
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
Major Holders Summary
13.13% Percentage of Shares held by All Insiders
18.85% Percentage of Shares held by All Institutions
21.7% Percentage of Float held by Institutions
64
Number of Institutions Holding SharesInstitutional Ownership
About 18.85% of ORMP shares are held by financial institutions. MCILRATH & ECK, LLC is the top corporate investor, holding 2K shares valued at $5.84K. A 0% stake in Oramed Pharmaceuticals Inc. is owned by the company. HRT FINANCIAL LP owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Insiders
Among the ORMP insiders holding of 13.13% of the stake in company, BRONFELD ZEEV, 10 percent owner, holds the largest shares of 5.81M. SANK LEONARD, director, is the second largest ORMP insider with ownership of 365K shares. LI XIAOPENG, director, stands third with possession of 206.35K shares of that stake.
Buying/Selling by Insiders
Frequently Asked Questions
How many institutions own ORMP stock?
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ORMP shares is 64, representing 18.85% of the company's common stock.
Who are the major shareholders selling Oramed Pharmaceuticals Inc. stock?
HRT FINANCIAL LP, in the last quarter, reduced its stake in ORMP by -100% restricting it's holding to 0 shares of worth nearly -. QUANTBOT TECHNOLOGIES LP also lessened -100% of the ORMP shares from its portfolio, reducing its holding to 0 shares of worth -. XTX TOPCO LTD also shunned ORMP shares holding by -100% last quarter which brought its holding to 0 shares worth -.
Investors who are buying ORMP stock?
As per its latest 13F filing, MURCHINSON LTD. increased its stake in ORMP by 31.38% in the last quarter. The institutional holder raised its holding to 1.38 million shares having worth more than $4.03M. BOOTHBAY FUND MANAGEMENT, LLC also added 31.38% more shares of ORMP to its portfolio, raising its holding to 689.75 thousand shares of worth $2.01M. BANK OF AMERICA CORP /DE/ also increased its ORMP shares holding by 5.77% which brought its holding to 287.05 thousand shares worth $838.19K.
ORMP's major insiders: who are they?
The insider with the most stakes in ORMP is Bronfeld Zeev , 10 percent owner at the company. Additionally, ORMP stock is highly held by director Sank Leonard and director Li Xiaopeng among others.
Did an insider recently sell ORMP stock?
Company executives, directors, and other insiders own 13.13% percent of Oramed Pharmaceuticals Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which ORMP insiders have sold stock, totaling 0 shares. Insiders that have sold shares include KIDRON MIRIAM, RABINOWITZ MICHAEL, and RAKIN KEVIN.
Which insider recently purchased ORMP stock?
There have been 0 transaction(s) during the past 6-months in which Oramed Pharmaceuticals Inc. insiders have bought stock, totalling 0 shares
How much of ORMP does insiders own?
Around 0 Oramed Pharmaceuticals Inc. shares are held by insiders, which represents about 13.13% of ORMP stock.
Who is the insider with the largest stake?
ORMP 10 percent owner, Bronfeld Zeev holds the largest portfolio of the company's shares. ORMP shares owned by Bronfeld total nearly 5.81 million.
Which institution holds the most shares in ORMP?
MCILRATH & ECK, LLC is the largest institutional owner in ORMP which holds 2 thousand shares worth $5.84K or 0% of the total ORMP shares outstanding followed by HRT FINANCIAL LP with ownership of 0 shares representing 0% of the ORMP ownership. QUANTBOT TECHNOLOGIES LP is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.
Is Oramed Pharmaceuticals Inc. stock optionable?
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ORMP is concerned, it is a stock which is optionable.
Is there a short position on ORMP's shares?
Number of ORMP shares short is 650.80K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
About how many outstanding ORMP shares are there?
As of today, 40.85M shares of ORMP are outstanding.
Is there many float in ORMP stock?
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ORMP has 32.47M shares in float.
ORMP short ratio: what is it?
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ORMP is 5.46.